|
Providing technical assistance to the National TB Programme (NTP), particularly on:
 developing TB control policies and strategies;
building capacity to sustain, improve and
further intensify Directly Observed Treatment Short-course (DOTS)
implementation;
scaling up and strengthening inter-sectoral partnerships for DOTS;
improving community awareness and utilization
of DOTS;
addressing HIV related TB and anti-TB drug
resistance under programme conditions;
measuring progress towards Millennium
Development Goals;
designing and disseminating information,
education and communication messages;
improving operational
research to strengthen DOTS implementation, together with the Department of
Medical Research.
Facilitating partnership, including with the
Global TB Drug Facility.
Providing technical expertise to the joint programme implementation through Technical Working Group
on TB.
Disseminating scientific information.
Organizing external two-yearly review of the
NTP.
Advocacy and raising commitment for TB
control.
Resource mobilization for TB and TB-HIV.
In-country presence of WHO Advisor for TB and
TB-HIV.
|
Nationwide survey of the prevalence of TB disease
successfully completed
|
|
With technical and financial support from the Japan
International Cooperation Agency, Population Services International, Research
Institute of Tuberculosis of Japan, Three Diseases Fund, United States
Agency for International Development and the World Health Organization, the
national TB prevalence survey was initiated in June 2009. The National
Tuberculosis Programme (NTP) screened 51,367 people
for TB in 70 geographical areas of the country and the challenging field
operations were accomplished on time in April 2010…
More Information
|
|
Myanmar
inaugurates state of the art TB laboratory
|
|
|
In 2008, UNITAID, an international facility for the
purchase of drugs and diagnostics for HIV/AIDS, tuberculosis and malaria,
approved funding for a project to accelerate access to diagnostics for
patients at risk of multidrug-resistant tuberculosis (MDR-TB) in 27
countries, including Myanmar…
More Information
|
|
Joint Supervisory visit to National TB Prevalence
Survey Site at Dedaye Township
|
|
|
Tuberculosis is one of the major public health problems
in Myanmar
which is one of 22 TB high burden countries. According to the 1994 National
TB Prevalence Survey the incidence of new sputum smear positive cases was
75 per 100,000 populations per year…
More Information
|
|
Launching Ceremony of the DOTS-Plus Programme for the Management of Multidrug Resistant
Tuberculosis (MDR-TB) in Myanmar
|
|
|
The Ministry of Health, Myanmar and the World Health
Organization organized the Launching ceremony of DOTS-Plus (Directly
Observed Treatment Short course - Plus) Programme
for the management of MDR-TB in Myanmar, on Thursday 9 July 2009, at 10:00
am, at the Training Hall of the National TB Reference Laboratory, in the
compound of TB Hospital Aung San, Yangon…
More
Information
|
|
National Workshop on Adopting and Adapting the
International Standards for TB Care (ISTC) in Myanmar, 4 – 5 March, 2009
|
|
|
The Ministry of Health, Myanmar,
in collaboration with WHO Country Office Myanmar
organized the National Workshop on Adopting and Adapting the International
Standards for TB Care in Myanmar
at Traders’ Hotel, 4-5 March 2009. The workshop was financially supported
by the United States Agency for International Development and WHO.
More Information
|
|
Ministry of Health Partners meeting on Sustainable
Tuberculosis (TB) Drug Supply in Myanmar
|
|
|
The Ministry of Health, Myanmar
with support from the WHO convened the Partners’ Meeting on “Sustainable TB
Drug Supply in Myanmar”
in Naypyitaw on 1st December 2008. The meeting
was chaired by the Minister for Health Professor Dr Kyaw Myint and attended
by the Deputy Ministers for Health Professor Mya Oo and Professor Paing
Soe, Director Generals and Deputy Director Generals of Departments under
the Ministry of Health, Ambassadors/Representatives of Embassies of United
Kingdom, Australia, United States of America, Japan, UN Resident
Representative/UN Resident Coordinator, Country Representatives of WHO,
UNICEF, UNDP, UNAIDS, Representatives of WHO HQ Geneva, the Global Drug Facility (GDF)
Monitoring Mission headed by the Chief of GDF, Representatives from Japan
International Cooperation Agency (JICA), United Kingdom Department for
International Development, Swedish International Development Cooperation
Agency, Director of the International Union against TB and Lung Diseases,
President and Chief Executive Officer of Population Services International
(PSI), the Foundation for Innovative New Diagnostics, the General Manager
of TOTAL Company, International non governmental organizations (PSI, World
Vision Myanmar, Pact Myanmar, Malteser
International), Officials from Ministry of Health, and special invited
guests.
More Information
|
|
A step forward on: TB HIV Collaborative Activities in
Myanmar
(The Basic Minimum Package of Interventions for TB/HIV at District/Township
level)
|
|
|
According to the sentinel results in 2005, about 7.1% of
TB sputum smear positive patients were found HIV positive. Since then, WHO
in collaboration with MOH re-initiated a pilot programme
in 2 high prevalence townships on collaborative prevention and control
activities for TB HIV.
More Information
|
|
